← Back to headlines
Altimmune a new buy at Truist on pemvidutide promise
Truist initiates coverage on Altimmune with a buy rating, citing the potential of its drug pemvidutide.
Sources
Showing 0 of 1 sources
Related Stories
New application in Greece prevents the sale of alcohol and cigarettes to minors
12m ago
As more youths get arrested for drugs, is the onus on parents to start conversations early?
33m ago
Tveggja vikna barn með herpes eftir umskurð
40m ago
Research shows morning sex can improve work motivation and chances of a raise
49m ago